149 related articles for article (PubMed ID: 24508781)
21. Synthesis and docking studies of novel benzopyran-2-ones with anticancer activity.
Ismail MM; Rateb HS; Hussein MM
Eur J Med Chem; 2010 Sep; 45(9):3950-9. PubMed ID: 20580139
[TBL] [Abstract][Full Text] [Related]
22. Chiral preference of L-tryptophan derived metal-based antitumor agent of late 3d-metal ions (Co(II), Cu(II) and Zn(II)) in comparison to D- and DL-tryptophan analogues: their in vitro reactivity towards CT DNA, 5'-GMP and 5'-TMP.
Arjmand F; Muddassir M; Khan RH
Eur J Med Chem; 2010 Sep; 45(9):3549-57. PubMed ID: 20537435
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure elucidation of a copper(II) Schiff-base complex: in vitro DNA binding, pBR322 plasmid cleavage and HSA binding studies.
Tabassum S; Ahmad M; Afzal M; Zaki M; Bharadwaj PK
J Photochem Photobiol B; 2014 Nov; 140():321-31. PubMed ID: 25222146
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization, biological studies (DNA binding, cleavage, antibacterial and topoisomerase I) and molecular docking of copper(II) benzimidazole complexes.
Arjmand F; Parveen S; Afzal M; Shahid M
J Photochem Photobiol B; 2012 Sep; 114():15-26. PubMed ID: 22695227
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies.
Arjmand F; Muddassir M; Yousuf I
J Photochem Photobiol B; 2014 Jul; 136():62-71. PubMed ID: 24857791
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of copper-based anticancer compound;
Al-Asbahy WM; Shamsi M
J Biomol Struct Dyn; 2021 Mar; 39(4):1431-1446. PubMed ID: 32090687
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and enantiopreferential DNA-binding profile of late 3d transition metal R- and S-enantiomeric complexes derived from N,N-bis-(1-benzyl-2-ethoxyethane): Validation of R-enantiomer of copper(II) complex as a human topoisomerase II inhibitor.
Arjmand F; Sharma GC; Muddassir M; Tabassum S
Chirality; 2011 Aug; 23(7):557-67. PubMed ID: 21695735
[TBL] [Abstract][Full Text] [Related]
28. Novel securinine derivatives as topoisomerase I based antitumor agents.
Hou W; Wang ZY; Peng CK; Lin J; Liu X; Chang YQ; Xu J; Jiang RW; Lin H; Sun PH; Chen WM
Eur J Med Chem; 2016 Oct; 122():149-163. PubMed ID: 27344492
[TBL] [Abstract][Full Text] [Related]
29. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
[TBL] [Abstract][Full Text] [Related]
30. Copper complexes with phosphonium containing hydrazone ligand: topoisomerase inhibition and cytotoxicity study.
Chew ST; Lo KM; Lee SK; Heng MP; Teoh WY; Sim KS; Tan KW
Eur J Med Chem; 2014 Apr; 76():397-407. PubMed ID: 24602785
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of β-carboline-benzimidazole conjugates using lanthanum nitrate as a catalyst and their biological evaluation.
Kamal A; Rao MP; Swapna P; Srinivasulu V; Bagul C; Shaik AB; Mullagiri K; Kovvuri J; Reddy VS; Vidyasagar K; Nagesh N
Org Biomol Chem; 2014 Apr; 12(15):2370-87. PubMed ID: 24604306
[TBL] [Abstract][Full Text] [Related]
32. Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand.
Seng HL; Wang WS; Kong SM; Alan Ong HK; Win YF; Raja Abd Rahman RN; Chikira M; Leong WK; Ahmad M; Khoo AS; Ng CH
Biometals; 2012 Oct; 25(5):1061-81. PubMed ID: 22836829
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes.
Arjmand F; Jamsheera A; Mohapatra DK
J Photochem Photobiol B; 2013 Apr; 121():75-85. PubMed ID: 23518161
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling.
Le TN; Yang SH; Khadka DB; Van HT; Cho SH; Kwon Y; Lee ES; Lee KT; Cho WJ
Bioorg Med Chem; 2011 Jul; 19(14):4399-404. PubMed ID: 21684168
[TBL] [Abstract][Full Text] [Related]
35. Mixed-ligand Cu(II)-vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity.
Tabassum S; Amir S; Arjmand F; Pettinari C; Marchetti F; Masciocchi N; Lupidi G; Pettinari R
Eur J Med Chem; 2013 Feb; 60():216-32. PubMed ID: 23291123
[TBL] [Abstract][Full Text] [Related]
36. Molecular docking, DFT and antimicrobial studies of Cu(II) complex as topoisomerase I inhibitor.
Parveen S; Arjmand F; Zhang Q; Ahmad M; Khan A; Toupet L
J Biomol Struct Dyn; 2021 Apr; 39(6):2092-2105. PubMed ID: 32174234
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological studies of steroidal pyran based derivatives.
Shamsuzzaman ; Dar AM; Khan Y; Sohail A
J Photochem Photobiol B; 2013 Dec; 129():36-47. PubMed ID: 24157729
[TBL] [Abstract][Full Text] [Related]
39. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
Ismail MA; Tratrat C; Haroun MG
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1331-45. PubMed ID: 22957723
[TBL] [Abstract][Full Text] [Related]
40. TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells.
Liu YP; Chen HL; Tzeng CC; Lu PJ; Lo CW; Lee YC; Tseng CH; Chen YL; Yang CN
Breast Cancer Res Treat; 2013 Apr; 138(2):383-93. PubMed ID: 23430225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
